A.P.J. Vlaar
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intravenously Administered M6229 in Critically Ill Sepsis Patients (NCT05208112) | A.P.J. Vlaar | 2022-04-05 |
Track A.P.J. Vlaar automatically
Every clearance here is in the API, with alerts when new ones post.